Generic pharmaceuticals group Actavis extends its US portfolio with first injectable product. Actavis Group, the international generic pharmaceuticals company, has received approval for Irinotecan Hydrochloride
Generic pharmaceuticals group Actavis extends its US portfolio with first injectable product. Actavis Group, the international generic pharmaceuticals company, has received approval for Irinotecan Hydrochloride
